First Horizon Corporation’s Emergent Biosolutions EBS Stock Holding History

First Horizon Corporation’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$6K	Hold	108	–	–	﹤0.01%	806
2021 Q1	$10K	Buy	108 +21	+24%	+$2.15K	﹤0.01%	676
2020 Q4	$7K	Sell	87 -19	-18%	-$1.74K	﹤0.01%	730
2020 Q3	$10K	Buy	+106	New	+$11.4K	﹤0.01%	614

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Horizon Corporation's EBS Position: Q2 2021 in Review

First Horizon Corporation held its Emergent Biosolutions (EBS) position steady in Q2 2021 at 108 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

First Horizon Corporation first reported a position in EBS in Q3 2020 and has held it in 4 quarters since. The position peaked at $10K in Q1 2021. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

First Horizon Corporation held 108 shares of Emergent Biosolutions worth $6K as of Q2 2021.
First Horizon Corporation left its Emergent Biosolutions share count unchanged in Q2 2021.
Emergent Biosolutions made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #806 holding.
First Horizon Corporation first reported a position in Emergent Biosolutions in Q3 2020 and has held it in 4 quarters since.
First Horizon Corporation's Emergent Biosolutions position peaked at $10K in Q1 2021.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.